Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayley Merkeley

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Ejhaem|July 18, 2022
IgD lambda plasma cell neoplasm with extensive AL amyloidosisMuntadhar Al Moosawi, Julia L Varghese, Hayley Merkeley, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 9, 2012
Ileocecal ulceration and granulomatous ileitis as an unusual presentation of typhoid feverChristopher Cheung, Hayley Merkeley, Jocelyn A Srigley, et al.
European Journal of Haematology|February 1, 2021
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case seriesSarah Hansen, Waleed Alduaij, Catherine M Biggs, et al.
American Journal of Hematology|January 6, 2023
A young woman with persistent sore throat, Epstein-Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cellsMariam Goubran, Eric McGinnis, Ryan J Stubbins, et al.
British Journal of Haematology|October 10, 2021
Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case reportChieh Min Benjamin Lai, Audi Setiadi, Angeliki Barlas, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
The Lancet Regional Health. Southeast Asia|April 15, 2025
Evaluation of low-cost techniques to detect sickle cell disease and β-thalassemia: an open-label, international, multicentre studyPranav Shrestha, Hendrik Lohse, Christopher Bhatla, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
Blood Advances|August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene AutotemcelJosu de la Fuente, Haydar Frangoul, Peter Lang, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Ejhaem|July 18, 2022
IgD lambda plasma cell neoplasm with extensive AL amyloidosisMuntadhar Al Moosawi, Julia L Varghese, Hayley Merkeley, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 9, 2012
Ileocecal ulceration and granulomatous ileitis as an unusual presentation of typhoid feverChristopher Cheung, Hayley Merkeley, Jocelyn A Srigley, et al.
European Journal of Haematology|February 1, 2021
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case seriesSarah Hansen, Waleed Alduaij, Catherine M Biggs, et al.
American Journal of Hematology|January 6, 2023
A young woman with persistent sore throat, Epstein-Barr virus, lymphadenopathy, and aberrant CD4 + CD7- T-cellsMariam Goubran, Eric McGinnis, Ryan J Stubbins, et al.
British Journal of Haematology|October 10, 2021
Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case reportChieh Min Benjamin Lai, Audi Setiadi, Angeliki Barlas, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
The Lancet Regional Health. Southeast Asia|April 15, 2025
Evaluation of low-cost techniques to detect sickle cell disease and β-thalassemia: an open-label, international, multicentre studyPranav Shrestha, Hendrik Lohse, Christopher Bhatla, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
Blood Advances|August 27, 2025
Improvements in Health-Related Quality of Life in Patients with Transfusion-Dependent β-Thalassemia After Exagamglogene AutotemcelJosu de la Fuente, Haydar Frangoul, Peter Lang, et al.
American Journal of Hematology|June 8, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-ThalassemiaSujit Sheth, Selim Corbacioglu, Josu de la Fuente, et al.
Pageof 2